Understanding the medical decision-making and information disclosure preferences is important for care quality.
Objectives:
To examine the feasibility of using the questionnaires and to identify modifications needed in the following study.
Design:
Thirty-three pairs of patients with advanced cancers and their caregivers were asked to complete the questionnaires.
Results:
More than 60% of patients and caregivers had an educational level of middle school and below. The active, passive, or shared decision-making preferences for patients were 33.3%, 39.4%, and 27.3%, respectively. Twenty of 33 patients and 24 of 33 caregivers misunderstood the questions.
Conclusions:
Low educational levels may be the reason for poor understanding imprecision. It is necessary to use the modification version of the questionnaires in developing countries.
KeatingNLGuadagnoliELandrumMBBorbasCWeeksJC. Treatment decision making in early-stage breast cancer: should surgeons match patients’ desired level of involvement?J Clin Oncol. 2002;20(6):1473–1479.
2.
GattellariMVoigtKJButowPNTattersallMH. When the treatment goal is not cure: are cancer patients equipped to make informed decisions?J Clin Oncol. 2002;20(2):503–513.
3.
Kagawa-SingerMBlackhallLJ. Negotiating cross-cultural issues at the end of life: you got to go where he lives. JAMA. 2001;286(23):2993–3001.
4.
PieterseAHBaas-ThijssenMCMarijnenCAStiggelboutAM. Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer. 2008;99(6):875–882.
5.
HubbardGKiddLDonaghyE. Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. Eur J Oncol Nurs. 2008;12(4):299–318.
6.
HagertyRGButowPNEllisPMDimitrySTattersallMH. Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol. 2005;16(7):1005–1053.
7.
StalmeierPFvan Tol-GeerdinkJJvan LinEN. Doctors’ and patients’ preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol. 2007;25(21):3096–3100.
8.
BrueraESweeneyCCalderKPalmerLBenisch-TolleyS. Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol. 2001;19(11):2883–2885.
9.
BrueraE. Process and content of decision making by advanced cancer patients. J Clin Oncol. 2006;24(7):1029–1030.
10.
GastonCMMitchellG. Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med. 2005;61(10):2252–2264.
11.
WangDCPengXGuoCBSuYJ. When clinicians telling the truth is de facto discouraged, what is the family’s attitude towards disclosing to a relative their cancer diagnosis?Support Care Cancer. 2013;21(4):1089–1095.
12.
LiaoZHaoJGuoYReyes-GibbyCGuoH. Assessment of cancer pain management knowledge in Southwest China: a survey of 259 physicians from small city and county hospitals. J Palliat Med. 2013;16(6):692–695.
13.
DegnerLFSloanJAVenkateshP. The Control Preferences Scale. Can J Nurs Res. 1997;29(3):21–43.
14.
DegnerLFSloanJA. Decision making during serious illness: what role do patients really want to play?J Clin Epidemiol. 1992;45(9):941–950.
15.
BrueraEWilleyJSPalmerJLRosalesM. Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer. 2002;94(7):2076–2080.
16.
HackTFPicklesTBultzBDRuetherJDDegnerLF. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psychooncology. 2007;16(6):543–552.
17.
O’ DonnellMMonzBHunskaarS. General preferences for involvement in treatment decision making among European women with urinary incontinence. Soc Sci Med. 2007;64(9):1914–1924.
18.
LukerKABeaverKLeinsterSJOwensRGDegnerLFSloanJA. The information needs of women newly diagnosed with breast cancer. J Adv Nurs. 1995;22(1):134–141.
19.
BilodeauBADegnerLF. Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum. 1996;23(4):691–696.
20.
YennurajalingamSBrueraE. Information disclosure and decision making preferences of patients with advanced cancer in a Pain and Palliative Care Unit in Chile. Rev Med Chile. 2014;142(1):48–54.
21.
GattellariMButowPNTattersallMH. Sharing decisions in cancer care. Soc Sci Med. 2001;52(12):1865–1878.
22.
MoHNShinDWWooJH. Is patient autonomy a critical determinant of quality of life in Korea? End-of-life decision making from the perspective of the patient. Palliat Med. 2012;26(3):222–231.
23.
HinesSCGloverJJHolleyJLBabrowASBadzekLAMossAH. Dialysis patients’ preferences for family-based advance care planning. Ann Intern Med. 1999;130(10):825–828.
24.
ElkinEBKimSHCasperESKissaneDWSchragD. Desire for information and involvement in treatment decisions: elderly cancer patients’ preferences and their physicians’ perceptions. J Clin Oncol. 2007;25(33):5275–5280.
25.
CaldonLJWaltersSJReedMW. Changing trends in the decision-making preferences of women with early breast cancer. Br J Surg. 2008;95(3):312–318.
26.
JeffordMTattersallMH. Informing and involving cancer patients in their own care. Lancet Oncol. 2002;3(10):629–637.
27.
HancockKClaytonJMParkerSM. Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med. 2007;21(6):507–517.
28.
HagertyRGButowPNEllisPA. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22(9):1721–1730.
29.
FriedTRBradleyEHO’LearyJ. Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc. 2003;51(10):1398–1403.
30.
JiangYLiJYLiuC. Different attitudes of oncology clinicians toward truth telling of different stages of cancer. Support Care Cancer. 2006;14(11):1119–1125.
31.
JiangYLiuCLiJY. Different attitudes of Chinese patients and their families toward truth telling of different stages of cancer. Psychooncology. 2007;16(10):928–936.
32.
LaxmiSKhanJA. Does the cancer patient want to know? Results from a study in an Indian tertiary cancer center. South Asian J Cancer. 2013;2(2):57–61.
33.
MystakidouKParpaETsililaEKatsoudaEVlahosL. Cancer information disclosure in different cultural contexts. Support Care Cancer. 2004;12(3):147–154.
34.
MystakidouKTsilikaEParpaEKatsoudaEVlahosL. Patterns and barriers in information disclosure between health care professionals and relatives with cancer patients in Greek society. Eur J Cancer Care (Engl). 2005;14(2):175–181.
35.
YunYHKwonYCLeeMK. Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol. 2010;28(11):1950–1957.
36.
ElwynTSFettersMDSasakiHTsudaT. Responsibility and cancer disclosure in Japan. Soc Sci Med. 2002;54(2):281–293.
37.
MystakidouKLiossiCVlachosLPapadimitriouJ. Disclosure of diagnostic information to cancer patients in Greece. Palliat Med. 1996;10(3):195–200.
38.
YunYHLeeCGKimSY. The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol. 2004;22(2):307–314.
39.
DahlstrandHHauksdottirAValdimarsdottirUFurstCJBergmarkKSteineckG. Disclosure of incurable illness to spouses: do they want to know? A Swedish population-based follow-up study. J Clin Oncol. 2008;26(20):3372–3379.
40.
ReesCEBathPA. The information needs and source preferences of women with breast cancer and their family members: a review of the literature published between 1988 and 1998. J Adv Nurs. 2000;31(4):833–841.
41.
HackTFDegnerLFWatsonPSinhaL. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psychooncology. 2006;15(1):9–19.
42.
ButowPNMacleanMDunnSMTattersallMHBoyerMJ. The dynamics of change: cancer patients’ preferences for information, involvement and support. Ann Oncol. 1997;8(9):857–863.
